Ginkgo Bioworks Earnings Estimate
| DNA Stock | USD 8.87 0.35 3.80% |
Ginkgo Bioworks Earnings Estimation Breakdown
The calculation of Ginkgo Bioworks' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Ginkgo Bioworks is estimated to be -1.335 with the future projection ranging from a low of -1.335 to a high of -1.335. Please be aware that this consensus of annual earnings estimates for Ginkgo Bioworks Holdings is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.33 Lowest | Expected EPS | -1.33 Highest |
Ginkgo Bioworks Earnings Projection Consensus
Suppose the current estimates of Ginkgo Bioworks' value are higher than the current market price of the Ginkgo Bioworks stock. In this case, investors may conclude that Ginkgo Bioworks is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Ginkgo Bioworks' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 4 | 49.62% | -1.45 | -1.335 | -6.18 |
Ginkgo Bioworks Earnings History
Earnings estimate consensus by Ginkgo Bioworks Holdings analysts from Wall Street is used by the market to judge Ginkgo Bioworks' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Ginkgo Bioworks' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Ginkgo Bioworks Quarterly Gross Profit |
|
Ginkgo Bioworks Earnings per Share Projection vs Actual
Actual Earning per Share of Ginkgo Bioworks refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Ginkgo Bioworks Holdings predict the company's earnings will be in the future. The higher the earnings per share of Ginkgo Bioworks, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Ginkgo Bioworks Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Ginkgo Bioworks, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Ginkgo Bioworks should always be considered in relation to other companies to make a more educated investment decision.Ginkgo Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Ginkgo Bioworks' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-11-06 | 2025-09-30 | -0.09 | -1.45 | -1.36 | 1511 | ||
2025-08-07 | 2025-06-30 | -0.1 | -1.1 | -1.0 | 1000 | ||
2025-06-13 | 2025-03-31 | -0.08 | -1.68 | -1.6 | 2000 | ||
2025-02-25 | 2024-12-31 | -0.0583 | -2.0 | -1.9417 | 3330 | ||
2024-11-11 | 2024-09-30 | -0.0682 | -1.08 | -1.0118 | 1483 | ||
2024-08-08 | 2024-06-30 | -0.08 | -0.11 | -0.03 | 37 | ||
2024-05-09 | 2024-03-31 | -0.08 | -0.08 | 0.0 | 0 | ||
2024-02-29 | 2023-12-31 | -0.1 | -0.11 | -0.01 | 10 | ||
2023-11-08 | 2023-09-30 | -0.09 | -0.16 | -0.07 | 77 | ||
2023-08-09 | 2023-06-30 | -0.08 | -0.09 | -0.01 | 12 | ||
2023-05-10 | 2023-03-31 | -0.09 | -0.11 | -0.02 | 22 | ||
2023-03-01 | 2022-12-31 | -0.21 | -0.09 | 0.12 | 57 | ||
2022-11-14 | 2022-09-30 | -0.3 | -0.41 | -0.11 | 36 | ||
2022-08-15 | 2022-06-30 | -0.04 | -0.43 | -0.39 | 975 | ||
2022-05-16 | 2022-03-31 | -0.03 | -0.3 | -0.27 | 900 | ||
2022-03-28 | 2021-12-31 | -0.04 | -0.99 | -0.95 | 2375 | ||
2021-11-15 | 2021-09-30 | -0.04 | -0.06 | -0.02 | 50 | ||
2021-05-24 | 2021-03-31 | 0 | 0.03 | 0.03 | 0 |
About Ginkgo Bioworks Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Ginkgo Bioworks earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Ginkgo Bioworks estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Ginkgo Bioworks fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -5.3 B | -5 B | |
| Retained Earnings Total Equity | -4 B | -4.2 B | |
| Earnings Yield | (1.23) | (1.17) | |
| Price Earnings Ratio | (0.84) | (0.88) | |
| Price Earnings To Growth Ratio | 0.03 | 0.02 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. Projected growth potential of Ginkgo fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Ginkgo Bioworks assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (6.18) | Revenue Per Share | Quarterly Revenue Growth (0.56) | Return On Assets | Return On Equity |
Understanding Ginkgo Bioworks Holdings requires distinguishing between market price and book value, where the latter reflects Ginkgo's accounting equity. The concept of intrinsic value - what Ginkgo Bioworks' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Ginkgo Bioworks' price substantially above or below its fundamental value.
It's important to distinguish between Ginkgo Bioworks' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ginkgo Bioworks should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Ginkgo Bioworks' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.